Both compounds support mitochondrial function, and there is some evidence that supplementation may benefit individuals with primary mitochondrial diseases

Pediatric Generalized Joint Hypermobility [pGJH] Subtypes: Pediatric generalized joint hypermobility Musculoskeletal Complications: Absent Skin and Tissue Abnormalities: Absent Core Comorbidities: Absent Pediatric Generalized Joint Hypermobility [pGJH] Subtypes: Pediatric generalized joint hypermobility with skin involvement Musculoskeletal Complications: Absent Skin and Tissue Abnormalities: Present Core Comorbidities: Absent Pediatric Generalized Joint Hypermobility [pGJH] Subtypes: Pediatric generalized joint hypermobility with core comorbidities Musculoskeletal Complications: Absent Skin and Tissue Abnormalities: Absent Core Comorbidities: Present Pediatric Generalized Joint Hypermobility [pGJH] Subtypes: Pediatric generalized joint hypermobility with core comorbidities and with skin involvement Musculoskeletal Complications: Absent Skin and Tissue Abnormalities: Present Core Comorbidities: Present Pediatric Generalized Hypermobility Spectrum Disorder [pgHSD] Subtypes: Pediatric generalized hypermobility spectrum disorder, musculoskeletal subtype Musculoskeletal Complications: Present Skin and Tissue Abnormalities: Absent Core Comorbidities: Absent Pediatric Generalized Hypermobility Spectrum Disorder [pgHSD] Subtypes: Pediatric generalized hypermobility spectrum disorder, musculoskeletal subtype with skin involvement Musculoskeletal Complications: Present Skin and Tissue Abnormalities: Present Core Comorbidities: Absent Pediatric Generalized Hypermobility Spectrum Disorder [pgHSD] Subtypes: Pediatric generalized hypermobility spectrum disorder, systemic subtype Musculoskeletal Complications: Present Skin and Tissue Abnormalities: Absent Core Comorbidities: Present Pediatric Generalized Hypermobility Spectrum Disorder [pgHSD] Subtypes: Pediatric generalized hypermobility spectrum disorder, systemic subtype with skin involvement Musculoskeletal Complications: Present Skin and Tissue Abnormalities: Present Core Comorbidities: Present Vascular EDS (vEDS) Genetic testing is used to see if a person has a genetic variant that causes vEDS

Cascinu S, Cordella L, del Ferro E, Fronzoni M, Catalano G
Standard dosing protocol Semaglutide dosing schedules are different for weight loss and diabetes management
Skin takes on a smooth, bright, and youthful appearance both instantly and over time